Patent ID: 6713269
Filing Date: 2004-03-30
Classification: A61K,C12N,G01N

Abstract:
A method for identifying putative therapeutic agents that may be useful for the treatemnt of osteoporosis which comprisesdetermining the mitogenic effect of the putative therapeutic agents and/or their effect on the differentiation of osteoblast precursor cells in standardized, pure primary cultures from osteoporotic patients prepared by sequential enztmatic digestion of transiliacal bone biopsies and cultivation osteoblast precursor cells, analyzing effects of the putative therapeutic agents on the following parameters with the osteoplast precursor cells from osteoporotic patients a) expression of intracellular proteins as determined on a high-resolution two dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis; b) a quantitative determination of the cell proliferation rate; and c) a determination of expression of at least six osteoblast-specific differentiation markers including, i) expression of c-myc, c-fos or c-jun as a parameter of the early differentiation phase of the osteoblasts, ii) intracellular synthesis of osteocalcin as a parameter of the late differentiation phase and, iii) expression of intracellular alkaline phosphatase, collagen type I, collagen type IV and chondroitin sulfate or hyaluronic acid as parameter of matrix synthesis; wherein said osteoblast precursor cells are cultured in a cell culture medium, which consists essentially of &agr;-MEM medium and HAM-F12 medium in a ratio of 1:3 to 3:1 and optionally serum in a concentration of 1-12%; and comparing the effects to the same parameters analyzed with the osteoplast precursor cells in the absence of the putative therapeutic agents.